Clustering trend of components of metabolic syndrome

International Journal of Cardiology

Volumn 121, Issue 1, 2007, Pages 117-118

  Aizawa, Yoshifusa ^a   Watanabe, Hiroshi ^a   Ramadan, Mahmoud M ^a   Usuda, Yoshimaru ^b   Watanabe, Tohru ^b   Sasaki, Shigeru ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Niigata Association for Comprehensive Health Promotion and Research   (Japan)

Author keywords

Clustering; Metabolic syndrome; Risk factors

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SAMPLE; STATISTICAL SIGNIFICANCE; UNITED STATES;

BODY MASS INDEX; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 34548096759     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.08.051     Document Type: Article

References (11)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
3. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66 (2002) 987-992
4. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
5. Boden-Albala B. Current understanding of multiple risk factors as the metabolic syndrome: distillation or deconstruction. Semin Neurol 26 (2006) 108-116
6. Hanley A.J., Karter A.J., Festa A., et al. Insulin resistance atherosclerosis study. factor analysis of metabolic syndrome using directly measured insulin sensitivity: the insulin resistance atherosclerosis study. Diabetes 51 (2002) 2642-2647
7. Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Morales P.A., and Stern M.P. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41 (1992) 715-722
8. Schmidt M.I., Watson R.L., Duncan B.B., et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism 45 (1996) 699-706
9. Meigs J.B. Definitions and mechanisms of the metabolic syndrome. Curr Opin Endocrinol Diabetes 13 (2006) 103-110
10. Kraja A.T., Rao D.C., Weder A.B., et al. An evaluation of the metabolic syndrome in a large multi-ethnic study: the family blood pressure program. Nutr Metab (Lond) 2 (2005) 17
11. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419